Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Biocept Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biocept Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Biocept Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biocept Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Biocept Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Biocept Inc, Medical Equipment, Deal Details 12
Partnerships 12
Biocept Enters into Marketing Agreement with Miraca Life Sciences 12
Biocept Enters into Agreement with University of Texas Southwestern Medical Center 13
Addario Lung Cancer Medical Institute and Biocept Enter into Partnership 14
Biocept Enters into Agreement with OHSU Knight Cancer Institute 15
Biocept Enters into Agreement with Catalyst Pharma 16
Biocept Enters into Agreement with Teneovita Medical Innovations 17
Biocept Forms Partnership with MedStar Georgetown University Hospital 18
Biocept to Form Partnership with Quest Diagnostics Mexico 19
Biocept Enters into Agreement 20
Biocept Enters into Distribution Agreement with Progenetics 21
Biocept Enters into Co-Development Agreement with Baylor College of Medicine 22
Biocept and Insight Genetics Enter into Agreement 23
Biocept Enters into Partnership with Life Technologies 24
Equity Offering 25
Biocept Raise USD11.6 Million in Rights Offering of Units 25
Biocept Prices Public Offering of Shares for USD2.5 Million 27
Biocept Raises USD14.8 Million in Public Offering of Shares and Warrants 29
Biocept Prices Public Offering of Shares for USD3.3 Million 31
Biocept Prices USD3.3 Million in Public Offering of Shares 33
Biocept Plans to Raise Funds through Private Placement of Shares 34
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 35
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 36
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 37
Biocept Prices Public Offering of Shares and Warrants for USD5 Million 38
Biocept to Raise USD15 Million in Public Offering of Shares 39
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 40
Biocept Completes IPO For US$19 Million 42
Biocept Raises USD2 Million in Private Placement of Series A Preferred Stock 43
Biocept Inc – Key Competitors 44
Biocept Inc – Key Employees 45
Biocept Inc – Locations And Subsidiaries 46
Head Office 46
Recent Developments 47
Financial Announcements 47
Aug 14, 2018: Biocept reports second quarter 2018 financial results 47
May 15, 2018: Biocept Announces First Quarter 2018 Financial Results 50
Mar 28, 2018: Biocept Reports 2017 Fourth Quarter and Full Year Financial Results 52
Nov 09, 2017: Biocept Reports Third Quarter 2017 Financial Results 55
Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results 58
May 11, 2017: Biocept Reports First Quarter 2017 Financial Results 61
Mar 07, 2017: Biocept Reports Fourth Quarter and Full Year 2016 Financial Results 63
Corporate Communications 65
Sep 10, 2018: Biocept names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer 65
Oct 11, 2017: Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept’s Clinical Advisory Board 66
Feb 15, 2017: Biocept Appoints Michael Terry Senior Vice President Commercial Operations 67
Government and Public Interest 68
Jan 30, 2018: Biocept Comments on Updated Consensus Medical Guidelines Recommending Liquid Biopsy for Profiling of Tumor Biomarkers to Assist with the Treatment of Patients with Lung Cancer 68
Product News 69
Sep 24, 2018: Biocept Awarded Patent in Hong Kong for its Target Selector Platform Using Antibodies and a Microchannel to Perform Liquid Biopsy 69
Aug 02, 2018: Biocept awarded patent in Canada for its target selector CTC platform 70
Jul 31, 2018: European patent granted for Biocept’s target selector oncogene mutation enrichment and detection platform 71
Jun 11, 2018: VWR and Biocept Announce the Launch of CEE-Sure Blood Collection Tubes for cfDNA and CTCs 72
Mar 20, 2018: Biocept to Present Recent Advances in Biomarker Identification from Liquid Biopsies at GTCbio’s 11th Biomarker Summit 73
Mar 15, 2018: Biocept’s Target Selector Platform Featured in Two Poster Presentations at the 2018 American Association for Cancer Research Annual Meeting 74
Feb 05, 2018: Biocept Receives Additional Patent Issuances in Three Major International Territories for its Target Selector Platform 75
Jan 04, 2018: Biocept Obtains Patent in Australia for its Molecular Biomarker Technology For the Detection of Cancer-Associated Mutations in Blood, Tissue, and Other Biological Sources 76
Dec 05, 2017: First U.S. Patent Issued for Biocept’s Target Selector Oncogene Mutation Enrichment and Detection Liquid Biopsy ctDNA Platform 77
Other Significant Developments 78
Jul 23, 2018: Biocept and UC San Diego Moores Cancer Center announce collaboration to study feasibility of liquid biopsy to predict disease recurrence in solid tumors and response to therapy 78
Jul 17, 2018: Alliance Global to market Biocept liquid biopsy tests 79
Mar 28, 2018: Biocept and Thermo Fisher Scientific Enter into Technology and Commercial Collaboration 80
Dec 18, 2017: Biocept Signs In-Network Provider Agreement with Wellmark Blue Cross Blue Shield Expanding Coverage for its Target Selector Platform in Iowa and South Dakota 81
Oct 18, 2017: Biocept Launches Pathology Partnership Initiative Expanding Access of Proprietary Liquid Biopsy Testing to Community Pathologists and Hospitals 82
Aug 14, 2017: Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR 83
Aug 07, 2017: Biocept Executes Preferred Provider Agreement with Scripps Health Plan Expanding Patient Coverage for its Liquid Biopsy Platform 84
Jun 21, 2017: Biocept and MediNcrease Health Plans Announce Provider Agreement Expanding Access to Liquid Biopsy Testing 85
Jan 10, 2017: Biocept Secures In-Network Provider Agreement with Blue Cross Blue Shield of Texas 86
Appendix 87
Methodology 87
About GlobalData 87
Contact Us 87
Disclaimer 87
Biocept Inc, Medical Equipment, Key Facts, 2017 2
Biocept Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Biocept Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biocept Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Biocept Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biocept Inc, Deals By Market, 2012 to YTD 2018 9
Biocept Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Biocept Enters into Marketing Agreement with Miraca Life Sciences 12
Biocept Enters into Agreement with University of Texas Southwestern Medical Center 13
Addario Lung Cancer Medical Institute and Biocept Enter into Partnership 14
Biocept Enters into Agreement with OHSU Knight Cancer Institute 15
Biocept Enters into Agreement with Catalyst Pharma 16
Biocept Enters into Agreement with Teneovita Medical Innovations 17
Biocept Forms Partnership with MedStar Georgetown University Hospital 18
Biocept to Form Partnership with Quest Diagnostics Mexico 19
Biocept Enters into Agreement 20
Biocept Enters into Distribution Agreement with Progenetics 21
Biocept Enters into Co-Development Agreement with Baylor College of Medicine 22
Biocept and Insight Genetics Enter into Agreement 23
Biocept Enters into Partnership with Life Technologies 24
Biocept Raise USD11.6 Million in Rights Offering of Units 25
Biocept Prices Public Offering of Shares for USD2.5 Million 27
Biocept Raises USD14.8 Million in Public Offering of Shares and Warrants 29
Biocept Prices Public Offering of Shares for USD3.3 Million 31
Biocept Prices USD3.3 Million in Public Offering of Shares 33
Biocept Plans to Raise Funds through Private Placement of Shares 34
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 35
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 36
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 37
Biocept Prices Public Offering of Shares and Warrants for USD5 Million 38
Biocept to Raise USD15 Million in Public Offering of Shares 39
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 40
Biocept Completes IPO For US$19 Million 42
Biocept Raises USD2 Million in Private Placement of Series A Preferred Stock 43
Biocept Inc, Key Competitors 44
Biocept Inc, Key Employees 45
List of Figures
Biocept Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Biocept Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Biocept Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Biocept Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Biocept Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biocept Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Biocept Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biocept Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
